Txoj Kev Siv Txoj Kev thiab Kev: Kev Koom Tes, Kev Sib Haum Xeeb thiab Yeej-Yeej
cov khoom

Cov khoom

Sitagliptin Phosphate CAS: 654671-78-0 Chaw Tsim Khoom Siv

Sitagliptin Phosphateyog thawj cov tshuaj dipeptidyl peptidase IV inhibitor tshiab los ntawm Merck rau kev kho mob ntshav qab zib hom 2 yam tsis nce qhov hnyav thiab qhov tshwm sim ntawm hypoglycemia zoo ib yam li placebo. Sitagliptin ua haujlwm los ntawm kev txhim kho lub cev incretin system, uas pab tswj cov piam thaj los ntawm kev cuam tshuam rau β thiab α hlwb hauv lub txiav.


Cov Lus Qhia Txog Khoom

Cov Cim Npe Khoom

Daim Ntawv Thov thiab Cov Nyhuv

Sitagliptin Phosphate yog ib hom tshuaj trizolopyrazine dipeptidyl peptidase IV inhibitor. Sitagliptin nyuam qhuav tau txais kev pom zoo rau kev kho mob ntshav qab zib hom II. Sitagliptin phosphate yog dipeptidyl peptidase Ⅳ (DDP-4) inhibitor pawg tshuaj uas tsim los ntawm lub tuam txhab German Merck thiab tau txais kev pom zoo los ntawm US Food and Drug Administration rau kev kho mob ntshav qab zib hom 2, yog ib hom tshuaj tiv thaiv kab mob ntshav qab zib tshiab, tuaj yeem txhim kho lub cev lub peev xwm los txo cov ntshav qab zib ntau, thiab ua rau cov incretin uas tshwm sim los ntawm kev txwv tsis pub ua haujlwm ntawm cov enzyme no, suav nrog cov glucagon-zoo li peptide 1 thiab glucose-dependent insulinotropic peptide, yog li ua rau lub pancreas txhim kho kev tsim insulin thiab nres kev tsim cov piam thaj hauv daim siab, thiab thaum kawg txo cov txiaj ntsig ntawm kev ntsuas ntshav qab zib.

Qauv Khoom

364 (1)
365 (1)

Khoom Ntim:

338(1)

Cov Lus Qhia Ntxiv:

Kev sau ua ke C16H15F6N5O.H3PO4
Kev Ntsuas 99%
Qhov tsos Dawb rau Off-White hmoov
CAS Nr. 654671-78-0
Ntim khoom 25KG
Lub Neej Txee 2 xyoos
Kev Khaws Cia Khaws cia rau qhov chaw txias thiab qhuav
Daim Ntawv Pov Thawj ISO.

  • Yav dhau los:
  • Tom ntej no:

  • Sau koj cov lus ntawm no thiab xa tuaj rau peb